OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 153
- No 13F data for Q4 2020
- Portfolio value
- $10.6B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 6,186,307 | $455.1M | 4.3% | – | – | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 13,944,680 | $453.2M | 4.3% | – | – | History |
| PRLDPrelude Therapeutics Inc | COM | 10,039,691 | $435.0M | 4.1% | – | – | History |
| 0000000000 | Stock | 11,895,652 | $421.7M | 4.0% | – | – | – |
| SPRYARS Pharmaceuticals, Inc. | COM | 8,740,887 | $381.4M | 3.6% | – | – | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 3,144,355 | $289.4M | 2.7% | – | – | History |
| MRKMerck & Co., Inc. | Stock | 3,732,400 | $287.7M | 2.7% | – | – | History |
| BMYBristol Myers Squibb Co | Stock | 4,515,400 | $285.1M | 2.7% | – | – | History |
| ABCLAbCellera Biologics Inc. | COM | 8,200,768 | $278.5M | 2.6% | – | – | History |
| BSXBoston Scientific Corp | Stock | 6,920,600 | $267.5M | 2.5% | – | – | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,135,900 | $244.1M | 2.3% | – | – | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 7,330,423 | $241.1M | 2.3% | – | – | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 2,361,327 | $223.4M | 2.1% | – | – | History |
| NTRANatera, Inc. | COM | 2,195,900 | $223.0M | 2.1% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 6,645,100 | $210.4M | 2.0% | – | – | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,221,200 | $209.2M | 2.0% | – | – | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 6,073,850 | $175.7M | 1.7% | – | – | History |
| XTNTXtant Medical Holdings, Inc. | COM NEW | 72,873,494 | $172.0M | 1.6% | – | – | History |
| UNHUnitedHealth Group Inc | Stock | 403,000 | $149.9M | 1.4% | – | – | History |
| GHGuardant Health, Inc. | COM | 977,400 | $149.2M | 1.4% | – | – | History |
| HUMHumana Inc | Stock | 313,600 | $131.5M | 1.2% | – | – | History |
| ABBVAbbVie Inc. | Stock | 1,213,200 | $131.3M | 1.2% | – | – | History |
| TBPHTheravance Biopharma, Inc. | COM | 6,219,110 | $126.9M | 1.2% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,301,715 | $126.6M | 1.2% | – | – | History |
| PASGPassage BIO, Inc. | COM | 6,962,899 | $121.7M | 1.1% | – | – | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 7,884,870 | $121.4M | 1.1% | – | – | – |
| KNTEKinnate Biopharma Inc. | COM | 3,847,929 | $119.9M | 1.1% | – | – | History |
| DXCMDexcom Inc | COM | 297,400 | $106.9M | 1.0% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 3,426,325 | $105.2M | 1.0% | – | – | History |
| KROSKeros Therapeutics, Inc. | COM | 1,679,417 | $103.4M | 1.0% | – | – | History |
| ISRGIntuitive Surgical Inc | COM NEW | 139,600 | $103.2M | 1.0% | – | – | History |
| ELVElevance Health, Inc. | Stock | 286,600 | $102.9M | 1.0% | – | – | History |
| ACETAdicet Bio, Inc. | COM | 7,232,856 | $94.6M | 0.9% | – | – | History |
| HAEHaemonetics Corp | COM | 852,000 | $94.6M | 0.9% | – | – | History |
| EWEdwards Lifesciences Corp | Stock | 1,126,400 | $94.2M | 0.9% | – | – | History |
| ETNB89bio, Inc. | COM | 3,729,442 | $88.3M | 0.8% | – | – | History |
| PGNYProgyny, Inc. | COM | 1,925,260 | $85.7M | 0.8% | – | – | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 3,791,204 | $83.4M | 0.8% | – | – | History |
| IMAImageneBio, Inc. | COM | 2,933,941 | $82.9M | 0.8% | – | – | History |
| SYKStryker Corp | Stock | 337,400 | $82.2M | 0.8% | – | – | History |
| IRONDisc Medicine, Inc. | COM | 5,826,224 | $78.9M | 0.7% | – | – | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 6,069,032 | $78.8M | 0.7% | – | – | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 2,578,174 | $74.0M | 0.7% | – | – | History |
| IMGNImmunoGen, Inc. | COM | 9,131,822 | $74.0M | 0.7% | – | – | History |
| AFIBAcutus Medical, Inc. | COM | 5,477,958 | $73.2M | 0.7% | – | – | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 552,500 | $67.3M | 0.6% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 505,159 | $65.1M | 0.6% | – | – | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,380,900 | $61.9M | 0.6% | – | – | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 8,466,783 | $61.6M | 0.6% | – | – | – |
| MGTXMeiraGTx Holdings plc | COM | 4,102,925 | $59.2M | 0.6% | – | – | History |
| MREOMereo BioPharma Group plc | SPON ADS | – | $58.2M | 0.5% | – | – | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,337,574 | $57.3M | 0.5% | – | – | History |
| DBTXDecibel Therapeutics, Inc. | COM | 4,945,192 | $56.2M | 0.5% | – | – | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 5,501,144 | $54.2M | 0.5% | – | – | History |
| OSHOak Street Health, Inc. | COM | 967,000 | $52.5M | 0.5% | – | – | History |
| BNRBurning Rock Biotech Ltd | SPONSORED ADS | 1,897,663 | $51.1M | 0.5% | – | – | History |
| TCDATricida, Inc. | COM | 9,614,280 | $50.9M | 0.5% | – | – | History |
| TMOThermo Fisher Scientific Inc. | Stock | 110,300 | $50.3M | 0.5% | – | – | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 1,206,886 | $49.8M | 0.5% | – | – | History |
| CRISCuris Inc | COM NEW | 4,366,494 | $49.4M | 0.5% | – | – | History |
| APTOAptose Biosciences Inc. | COM NEW | 8,030,000 | $48.0M | 0.5% | – | – | History |
| HARPHarpoon Therapeutics, Inc. | COM | 2,285,704 | $47.8M | 0.5% | – | – | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,146,145 | $47.8M | 0.5% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 5,694,841 | $47.6M | 0.4% | – | – | History |
| TELATELA Bio, Inc. | COM | 3,027,542 | $45.1M | 0.4% | – | – | History |
| XENEXenon Pharmaceuticals Inc. | COM | 2,497,917 | $44.7M | 0.4% | – | – | History |
| APLTApplied Therapeutics, Inc. | COM | 2,257,387 | $42.3M | 0.4% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 2,753,567 | $42.1M | 0.4% | – | – | History |
| SIBNSI-BONE, Inc. | COM | 1,305,300 | $41.5M | 0.4% | – | – | History |
| NSTGNS Wind Down Co., Inc. | COM | 622,900 | $40.9M | 0.4% | – | – | History |
| MOHMolina Healthcare, Inc. | COM | 162,400 | $38.0M | 0.4% | – | – | History |
| KALAKALA BIO, Inc. | COM | 5,465,030 | $36.8M | 0.3% | – | – | History |
| VORVor Biopharma Inc. | COM | 833,333 | $35.9M | 0.3% | – | – | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,224,770 | $34.6M | 0.3% | – | – | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 3,165,200 | $34.0M | 0.3% | – | – | – |
| QUREuniQure N.V. | SHS | 969,079 | $32.6M | 0.3% | – | – | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 3,070,955 | $32.6M | 0.3% | – | – | History |
| SCPHscPharmaceuticals Inc. | COM | 4,797,148 | $31.9M | 0.3% | – | – | History |
| SYRESpyre Therapeutics, Inc. | COM | 4,015,524 | $31.8M | 0.3% | – | – | History |
| Pandion Therapeutics Inc698340106 | COM | 528,229 | $31.7M | 0.3% | – | – | – |
| MRSNMersana Therapeutics, Inc. | COM | 1,892,500 | $30.6M | 0.3% | – | – | History |
| NMTR9 Meters Biopharma, Inc. | COM | 25,716,755 | $30.1M | 0.3% | – | – | History |
| NVAXNovavax Inc | COM NEW | 155,833 | $28.3M | 0.3% | – | – | History |
| NXTCNextCure, Inc. | COM | 2,711,013 | $27.1M | 0.3% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,584,845 | $26.2M | 0.2% | – | – | – |
| SRRASierra Oncology, Inc. | COM NEW | 1,477,320 | $25.5M | 0.2% | – | – | History |
| DMRADamora Therapeutics, Inc. | COM | 4,090,937 | $24.9M | 0.2% | – | – | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 8,053,298 | $24.8M | 0.2% | – | – | History |
| CALCCalciMedica, Inc. | COM SHS | 4,163,347 | $23.1M | 0.2% | – | – | History |
| ELVNEnliven Therapeutics, Inc. | COM | 2,719,902 | $23.0M | 0.2% | – | – | History |
| BIIBBiogen Inc. | COM | 82,000 | $22.9M | 0.2% | – | – | History |
| AMGNAmgen Inc | Stock | 91,500 | $22.8M | 0.2% | – | – | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 1,479,733 | $22.4M | 0.2% | – | – | History |
| CTICCti Biopharma Corp | COM | 7,520,600 | $21.9M | 0.2% | – | – | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 656,126 | $21.8M | 0.2% | – | – | History |
| LABStandard Biotools Inc. | COM | 4,599,571 | $20.8M | 0.2% | – | – | History |
| FLXNFlexion Therapeutics Inc | COM | 2,308,083 | $20.7M | 0.2% | – | – | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,250,001 | $19.4M | 0.2% | – | – | History |
| JNCEJounce Therapeutics, Inc. | COM | 1,823,600 | $18.7M | 0.2% | – | – | History |
| GILDGilead Sciences, Inc. | Stock | 287,600 | $18.6M | 0.2% | – | – | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.